FLT3 and acute myeloid leukemia: Collectively, these findings indicate that combination of IHCH9033 and quizartinib exerted strong synergistic antitumor efficacy both in FLT3-ITD AML mouse xenografts and primary patient samples by inhibiting DNA repair processes and accumulating DNA damage.